Institutional Ownership Nektar Therapeutics (NKTR)
This table provides information about the institutional ownership of Nektar Therapeutics (NKTR). We have compiled data on the 140 institutions that hold shares in the stock, with a total of 135 Million shares, which have been reported (via 13F filing form) to have a value of $149 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Kimelman & Baird, LLC
New York, NY |
Aug 19, 2024 Q2 2024 |
200
shares
|
$234
0.0% of portfolio
|
Q2 2024
New holding
|
|
Signaturefd, LLC
Atlanta, GA |
Jul 29, 2024 Q2 2024 |
200
shares
|
$234
0.0% of portfolio
|
Q4 2023
Reduced 93.75%
|
|
Versant Capital Management, Inc
|
Jul 05, 2024 Q2 2024 |
169
shares
|
$197
0.0% of portfolio
|
Q4 2023
Reduced 77.53%
|
|
Harbour Investments, Inc.
Madison, WI |
Jul 26, 2024 Q2 2024 |
155
shares
|
$181
0.0% of portfolio
|
Q4 2021
Reduced 50.48%
|
|
Princeton Global Asset Management LLC
|
Aug 12, 2024 Q2 2024 |
100
shares
|
$117
0.0% of portfolio
|
Q1 2022
New holding
|
|
Salomon & Ludwin, LLC
|
Jul 25, 2024 Q2 2024 |
46
shares
|
$53
0.0% of portfolio
|
Q3 2023
New holding
|
|
Steward Partners Investment Advisory, LLC
|
Aug 08, 2024 Q2 2024 |
40
shares
|
$46
0.0% of portfolio
|
Q2 2024
Reduced 80.0%
|
|
Global Retirement Partners, LLC
|
Jul 23, 2024 Q2 2024 |
16
shares
|
$18
0.0% of portfolio
|
Q1 2023
New holding
|
|
Covestor LTD
Boston, MA |
Aug 09, 2024 Q2 2024 |
5
shares
|
$5
0.0% of portfolio
|
Q2 2024
Reduced 80.0%
|
|
Huntington National Bank
Columbus, OH |
Aug 08, 2024 Q2 2024 |
1
shares
|
$1
0.0% of portfolio
|
Q1 2020
Reduced 99.88%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Jul 23, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|